R Willemze1, E Hodak, P L Zinzani, L Specht, M Ladetto. Show Affiliations » 1. Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useEurope/epidemiologyHumansKi-1 Antigen/metabolismLymph Nodes/pathologyLymphoma, Extranodal NK-T-Cell/diagnosisLymphoma, Extranodal NK-T-Cell/drug therapyLymphoma, Extranodal NK-T-Cell/radiotherapyLymphoma, Primary Cutaneous Anaplastic Large Cell/diagnosisLymphoma, Primary Cutaneous Anaplastic Large Cell/therapyLymphoma, T-Cell/drug therapyLymphoma, T-Cell/mortalityLymphoma, T-Cell, Cutaneous/diagnosisLymphoma, T-Cell, Cutaneous/epidemiologyLymphoma, T-Cell, Cutaneous/therapyMycosis Fungoides/diagnosisMycosis Fungoides/drug therapyMycosis Fungoides/radiotherapyNeoplasm StagingPanniculitis/drug therapyPanniculitis/mortalityPositron-Emission TomographySezary Syndrome/drug therapySezary Syndrome/radiotherapySkin/pathologySkin Neoplasms/diagnosisSkin Neoplasms/epidemiologySkin Neoplasms/therapy
Substances: See more » Antineoplastic AgentsKi-1 Antigen
Year: 2013 PMID: 23868906 DOI: 10.1093/annonc/mdt242
Source DB: PubMed Journal: Ann Oncol ISSN: 0923-7534 Impact factor: 32.976